These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
5. [Advantage and disadvantages of single-pill (fixed) antihypertensive drug combinations]. Umemura S Nihon Rinsho; 2011 Nov; 69(11):2042-8. PubMed ID: 22111328 [TBL] [Abstract][Full Text] [Related]
6. ESH-ESC guidelines for the management of hypertension. Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473 [TBL] [Abstract][Full Text] [Related]
7. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737 [TBL] [Abstract][Full Text] [Related]
8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
9. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ; Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590 [TBL] [Abstract][Full Text] [Related]
10. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients. Neutel JM Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863 [TBL] [Abstract][Full Text] [Related]
11. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy. Basile J; Neutel J Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):119-27. PubMed ID: 20042448 [TBL] [Abstract][Full Text] [Related]
12. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program). Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM; Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012 [TBL] [Abstract][Full Text] [Related]
13. [French as 2005-recommendations on the management of arterial hypertension]. Chamontin B; Halimi JM Arch Mal Coeur Vaiss; 2007 Jan; 100(1):42-6. PubMed ID: 17405553 [TBL] [Abstract][Full Text] [Related]
14. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension. Frampton JE; Scott LJ Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840 [TBL] [Abstract][Full Text] [Related]
15. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C; Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [TBL] [Abstract][Full Text] [Related]
16. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner. Roberts ME; Epstein BJ J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098 [TBL] [Abstract][Full Text] [Related]
17. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy. Deedwania PC Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743 [TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension. Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822 [TBL] [Abstract][Full Text] [Related]
19. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine. Ferri C; Croce G; Desideri G Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492 [TBL] [Abstract][Full Text] [Related]
20. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice. Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]